Pyxis Oncology annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Pyxis Oncology Depreciation & Amortization Growth & History (PYXS)
Pyxis Oncology's depreciation and amortization was $4.5M for fiscal 2025.
View full Pyxis Oncology company overviewPyxis Oncology annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.5M | $1.5M | +51.27% |
| 2024 | 2024-12-31 | $3.0M | $1.1M | +54.75% |
| 2023 | 2023-12-31 | $1.9M | $1.2M | +171.79% |
| 2022 | 2022-12-31 | $709,000 | $62,000 | +9.58% |
| 2021 | 2021-12-31 | $647,000 | $178,000 | +37.95% |
| 2020 | 2020-12-31 | $469,000 | — | — |
Pyxis Oncology quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $301,000 | −$234,000 | −43.74% |
| Q1 2026 | 2026-03-31 | $459,000 | −$93,000 | −16.85% |
| Q4 2025 | 2025-12-31 | $2.9M | — | — |
| Q3 2025 | 2025-09-30 | $527,000 | −$204,000 | −27.91% |
| Q2 2025 | 2025-06-30 | $535,000 | −$50,000 | −8.55% |
| Q1 2025 | 2025-03-31 | $552,000 | −$564,000 | −50.54% |
| Q3 2024 | 2024-09-30 | $731,000 | $208,000 | +39.77% |
| Q2 2024 | 2024-06-30 | $585,000 | $61,000 | +11.64% |
| Q1 2024 | 2024-03-31 | $1.1M | $926,000 | +487.37% |
| Q3 2023 | 2023-09-30 | $523,000 | $323,000 | +161.50% |
| Q2 2023 | 2023-06-30 | $524,000 | $365,000 | +229.56% |
| Q1 2023 | 2023-03-31 | $190,000 | $32,000 | +20.25% |
| Q3 2022 | 2022-09-30 | $200,000 | $41,000 | +25.79% |
| Q2 2022 | 2022-06-30 | $159,000 | −$58,000 | −26.73% |
| Q1 2022 | 2022-03-31 | $158,000 | $45,000 | +39.82% |
| Q3 2021 | 2021-09-30 | $159,000 | — | — |
| Q2 2021 | 2021-06-30 | $217,000 | — | — |
| Q1 2021 | 2021-03-31 | $113,000 | — | — |
Pyxis Oncology depreciation and amortization trends
Over the last five fiscal years, Pyxis Oncology's depreciation and amortization increased from $469,000 to $4.5M, a change of $4.0M. The latest reported quarter, Q2 2026, shows $301,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pyxis Oncology source filings ↗